Zobrazeno 1 - 10
of 127
pro vyhledávání: '"SACHIKO OGASAWARA"'
Autor:
Kosuke Ueda, Keiichiro Uemura, Naoki Ito, Yuya Sakai, Satoshi Ohnishi, Hiroki Suekane, Hirofumi Kurose, Tasuku Hiroshige, Katsuaki Chikui, Kiyoaki Nishihara, Makoto Nakiri, Shigetaka Suekane, Sachiko Ogasawara, Hirohisa Yano, Tsukasa Igawa
Publikováno v:
Current Oncology, Vol 31, Iss 4, Pp 1701-1712 (2024)
Immuno-oncology (IO) combination therapy is the first-line treatment for advanced renal cell carcinoma (RCC). However, biomarkers for predicting the response to IO combination therapy are lacking. Here, we investigated the association between the exp
Externí odkaz:
https://doaj.org/article/11f53d13330b4e1285ae6a5190539e9a
Autor:
Nao Nishida, Jun Ohashi, Goki Suda, Takehiro Chiyoda, Nobuharu Tamaki, Takahiro Tomiyama, Sachiko Ogasawara, Masaya Sugiyama, Yosuke Kawai, Seik-Soon Khor, Masao Nagasaki, Akihiro Fujimoto, Takayo Tsuchiura, Miyuki Ishikawa, Koichi Matsuda, Hirohisa Yano, Tomoharu Yoshizumi, Namiki Izumi, Kiyoshi Hasegawa, Naoya Sakamoto, Masashi Mizokami, Katsushi Tokunaga
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 5, p 4761 (2023)
The development of liver cancer in patients with hepatitis B is a major problem, and several models have been reported to predict the development of liver cancer. However, no predictive model involving human genetic factors has been reported to date.
Externí odkaz:
https://doaj.org/article/2ef071f4f95b4c1aaaf7374f5a3d1ba7
Autor:
Akiko Sumi, Jun Akiba, Sachiko Ogasawara, Masamichi Nakayama, Yoriko Nomura, Makiko Yasumoto, Sakiko Sanada, Osamu Nakashima, Toshi Abe, Hirohisa Yano
Publikováno v:
PLoS ONE, Vol 10, Iss 3, p e0118452 (2015)
Des-γ-carboxyprothrombin (DCP) has been used as a tumor marker for hepatocellular carcinoma (HCC). Recently the DCP/NX-DCP ratio, calculated by dividing DCP by NX-DCP, has been reported useful in detecting HCC. The purpose of this study is to clarif
Externí odkaz:
https://doaj.org/article/299cd1fa602a4c5ba9b471d79f443669
Autor:
Hironori Kusano, Jun Akiba, Sachiko Ogasawara, Sakiko Sanada, Makiko Yasumoto, Masamichi Nakayama, Keiko Ueda, Kosuke Ueda, Takashi Kurita, Keita Todoroki, Yumi Umeno, Osamu Nakashima, Hirohisa Yano
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e83195 (2013)
We investigated the effects of pegylated interferon-α2a (PEG-IFN-α2a) on the growth of human liver cancer cells.The effect of PEG-IFN-α2a on the proliferation of 13 liver cancer cell lines was investigated in vitro. Cells were cultured with medium
Externí odkaz:
https://doaj.org/article/f3ed72451f9e42b2bd98b5e6cfe82c56
Autor:
Sakiko Sanada, Kazunobu Futami, Atsumu Terada, Koji Yonemoto, Sachiko Ogasawara, Jun Akiba, Makiko Yasumoto, Akiko Sumi, Kimio Ushijima, Toshiharu Kamura, Yasuhiro Furuichi, Hirohisa Yano
Publikováno v:
PLoS ONE, Vol 8, Iss 8, p e72820 (2013)
OBJECTIVE: This study analyzed the clinicopathological correlation between ovarian cancer (OC) and RECQL1 DNA helicase to assess its therapeutic potential. METHODS: Surgically resected OC from 118 retrospective cases, for which paraffin blocks and al
Externí odkaz:
https://doaj.org/article/71c892deb8944498bc00a47f0238872b
Autor:
Kosuke Ueda, Sachiko Ogasawara, Jun Akiba, Masamichi Nakayama, Keita Todoroki, Keiko Ueda, Sakiko Sanada, Shigetaka Suekane, Masanori Noguchi, Kei Matsuoka, Hirohisa Yano
Publikováno v:
PLoS ONE, Vol 8, Iss 10, p e75463 (2013)
Cancer stem cells (CSC) or cancer stem cell-like cells (CSC-LCs) have been identified in many malignant tumors. CSCs are proposed to be related with drug resistance, tumor recurrence, and metastasis and are considered as a new target for cancer treat
Externí odkaz:
https://doaj.org/article/112e8ffc64464a41814a28094deb8bce
Publikováno v:
Cancer Genomics & Proteomics (1109-6535); May/Jun2024, Vol. 21 Issue 3, p260-271, 12p
Autor:
JUN AKIBA, MASAMICHI NAKAYAMA, REIICHIRO KONDO, HIRONORI KUSANO, SACHIKO OGASAWARA, YUTARO MIHARA, MASAHIKO TANIGAWA, KANA TSUTSUI, YUTA YANO, DAIKI MIYAZAKI, SAEKO TOKISAWA, TOSHIYUKI MITSUHASHI, HIDETOSHI NOMURA, SAKIKO SANADA, HISAMUNE SAKAI, TORU HISAKA, HIROHISA YANO
Publikováno v:
In Vivo; Mar/Apr2024, Vol. 38 Issue 2, p640-646, 7p
Autor:
Kumichika Uchida, Toru Aoyama, Yuji Terai, Naomi Yamaguchi, Shingo Kato, Koji Yakabi, Jun Kikuchi, Sachiko Ogasawara, Hirohisa Yano, Sumiko Nagoshi
Publikováno v:
Kanzo. 63:238-245
Autor:
Shinji, Mizuochi, Jun, Akiba, Reiichiro, Kondo, Hironori, Kusano, Taro, Shioga, Keiichi, Kondo, Kana, Tsutsui, Masamichi, Nakayama, Sachiko, Ogasawara, Yoshiki, Naito, Osamu, Nakashima, Hirohisa, Yano
Publikováno v:
Anticancer Research. 42:449-457
Non-B non-C hepatocellular carcinomas (NBNC-HCCs) are larger than hepatitis virus-related HCCs. We conducted a clinicopathological study of patients who underwent curative NBNC-HCC resection, including proliferative activity assessments, such as nucl